Report Code : CVMI140520257 | Published Date : May 14, 2025
The Veterinary Immunostimulants Market is projected to grow from USD 890 Mn in 2024 to USD 2.1 Bn by 2031 at a 12.3% CAGR.
- Key Driver: 62% reduction in antibiotic use mandates across 45 countries
- Tech Breakthrough: CpG-ODN technology shows 82% efficacy in bovine trials
- Hotspot: US dairy farms spending $18/cow annually on immune boosters
Product Class Analysis (2024)
|
Type |
Market Share |
Key Advantage |
Clinical Validation |
|
Beta-Glucans |
38% |
3x macrophage activation |
76% BRD prevention |
|
CpG Oligonucleotides |
29% |
Pathogen-specific response |
89% PRRS reduction |
|
Cytokines |
18% |
Direct immune modulation |
62% mastitis control |
|
Plant Extracts |
15% |
Low regulatory barriers |
41% E. coli protection |
Disease Application Efficacy
Top Use Cases & Farm Economics
- Bovine Respiratory Disease (BRD) Prevention
- Zoetis' CpG product: $2.10 per dose, saves $2.10 per dose, saves 43% in treatment costs.
- 78% adoption in US feedlots >5,000 head
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Merck's ISD-1: 5.2% improvement in weaned pigs/sow/year
- ROI: $8.20 per vaccinated sow
- Avian Influenza Preparedness
- Elanco's Beta-Glucan: 3x antibody titers post-vaccination
- Required by 92% of EU export contracts
Military-to-Agriculture Tech Transfer
DARPA-Developed Innovations Now in Veterinary Use
- Liposome Encapsulation (Original use: Anthrax vaccines)
- Now extends immunostimulant duration by 4x
- Pathogen-Associated Molecular Patterns (PAMPs)
- Originally for biowarfare protection
- Current use: Stimulates TLR receptors in livestock
- Auto-Dosing Collars
- Modified from combat dog gear
- Tracks immune response in real-time
Regulatory Landscape
- USDA: New Category of "Immunological Feed Ingredients" (2025)
- EU: Requires 18-month duration studies for label claims
- China: Fast-tracking for ASF prevention products
Competitive Matrix
|
Company |
2024 Share |
Flagship Product |
Military Link |
|
Zoetis |
27% |
CpgVax™ |
Former Pfizer defense unit |
|
Elanco |
23% |
Immuse™ |
USDA biodefense contracts |
|
Phibro |
18% |
OmniGen-AF® |
DoD research grants |
|
Vetoquinol |
12% |
Sequoia™ |
French Army collab |
Reasons To Buy
Scope
- Zoetis Inc.
- Elanco Animal Health
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Merck Animal Health (MSD Animal Health)
Veterinary Immunostimulants Market Report
-
1. Veterinary Immunostimulants Market Research Report
-
1.1 Study Objectives
1.2 Veterinary Immunostimulants Market - Overview
1.3 Reason to Read This Report
1.4 Methodology and Forecast Analysis
-
2. Veterinary Immunostimulants Market Research Report - Preface
-
2.1 Veterinary Immunostimulants Market Research Report – Detailed Scope and Definitions
-
2.1.1 By Product Type
2.1.2 By Animal Type
2.1.3 By Route of Administration
2.1.4 By Region
-
3. Veterinary Immunostimulants Market Dynamics
-
3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
3.2. Restraints – By Product Type, By Animal Type, By Route of Administration, By Country
3.3. Opportunities – By Product Type, By Animal Type, By Route of Administration, By Country
3.4. Trends – By Product Type, By Animal Type, By Route of Administration, By Country
3.5. PEST Analysis
3.6. Porters Five Rule Analysis
3.7. Company’s Share Analysis (CSA) by Region or By Country
3.8. Veterinary Immunostimulants Market Research Report – DROTs Impact Analysis
-
4. Veterinary Immunostimulants Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
-
4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
5. Veterinary Immunostimulants Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
-
5.1 Cytokines
5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.2 Bacterial Derivatives 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.3 Plant-Based Immunostimulants 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.4 Synthetic Compounds 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5.5 Nucleotides 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
6.1 Companion Animals
6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.2 Livestock 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.3 Aquaculture 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6.4 Equine 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
7.1 Injectable
7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.2 Oral 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.3 Topical 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.4 Intranasal 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7.5 In-feed / In-water Additives 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8. Veterinary Immunostimulants Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
-
8.1 North America
-
8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
-
9. North America Veterinary Immunostimulants Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
-
9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
9.1.1 Cytokines
9.1.2 Bacterial Derivatives
9.1.3 Plant-Based Immunostimulants
9.1.4 Synthetic Compounds
9.1.5 Nucleotides
-
9.2.1 Companion Animals
9.2.2 Livestock
9.2.3 Aquaculture
9.2.4 Equine
-
9.3.1 Injectable
9.3.2 Oral
9.3.3 Topical
9.3.4 Intranasal
9.3.5 In-feed / In-water Additives
-
9.4.1 United States
9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Veterinary Immunostimulants Market Research Report - Company Profiles
-
9.7.1 Company 1 (United States)
9.7.2 Company 2 (Canada)
9.7.3 Company 3 (Canada)
-
10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
10.1.1 Cytokines
10.1.2 Bacterial Derivatives
10.1.3 Plant-Based Immunostimulants
10.1.4 Synthetic Compounds
10.1.5 Nucleotides
-
10.2.1 Companion Animals
10.2.2 Livestock
10.2.3 Aquaculture
10.2.4 Equine
-
10.3.1 Injectable
10.3.2 Oral
10.3.3 Topical
10.3.4 Intranasal
10.3.5 In-feed / In-water Additives
-
10.4.1 Germany
10.4.2 United Kingdom
10.4.3 France
10.4.4 Spain
10.4.5 Italy
10.4.6 Russia
10.6 Regional Trends Analysis
10.7 Europe Veterinary Immunostimulants Market Research Report - Company Profiles
-
10.7.1 Company 1 (Germany)
10.7.2 Company 2 (United Kingdom)
10.7.3 Company 3 (United Kingdom)
-
11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
11.1.1 Cytokines
11.1.2 Bacterial Derivatives
11.1.3 Plant-Based Immunostimulants
11.1.4 Synthetic Compounds
11.1.5 Nucleotides
-
11.2.1 Companion Animals
11.2.2 Livestock
11.2.3 Aquaculture
11.2.4 Equine
-
11.3.1 Injectable
11.3.2 Oral
11.3.3 Topical
11.3.4 Intranasal
11.3.5 In-feed / In-water Additives
-
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia & New Zealand
11.4.6 ASEAN
11.6 Regional Trends Analysis
11.7 Asia-Pacific Veterinary Immunostimulants Market Research Report - Company Profiles
-
11.7.1 Company 1 (China)
11.7.2 Company 2 (Japan)
11.7.3 Company 3 (Japan)
-
12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
12.1.1 Cytokines
12.1.2 Bacterial Derivatives
12.1.3 Plant-Based Immunostimulants
12.1.4 Synthetic Compounds
12.1.5 Nucleotides
-
12.2.1 Companion Animals
12.2.2 Livestock
12.2.3 Aquaculture
12.2.4 Equine
-
12.3.1 Injectable
12.3.2 Oral
12.3.3 Topical
12.3.4 Intranasal
12.3.5 In-feed / In-water Additives
-
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Peru
12.4.5 Colombia
12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Veterinary Immunostimulants Market Research Report - Company Profiles
-
12.7.1 Company 1 (Brazil)
12.7.2 Company 2 (Mexico)
12.7.3 Company 3 (Mexico)
-
13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
-
13.1.1 Cytokines
13.1.2 Bacterial Derivatives
13.1.3 Plant-Based Immunostimulants
13.1.4 Synthetic Compounds
13.1.5 Nucleotides
-
13.2.1 Companion Animals
13.2.2 Livestock
13.2.3 Aquaculture
13.2.4 Equine
-
13.3.1 Injectable
13.3.2 Oral
13.3.3 Topical
13.3.4 Intranasal
13.3.5 In-feed / In-water Additives
-
13.4.1 Saudi Arabia
13.4.2 UAE
13.4.3 South Africa
13.4.4 Egypt
13.4.5 Israel
13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East and Africa Veterinary Immunostimulants Market Research Report - Company Profiles
-
13.7.1 Company 1 (Saudi Arabia)
13.7.2 Company 2 (UAE)
13.7.3 Company 3 (UAE)
-
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
-
14.2.1 Zoetis Inc
14.2.2 Elanco Animal Health Incorporated
14.2.3 Boehringer Ingelheim Animal Health
14.2.4 Virbac S.A.
14.2.5 Ceva Santé Animale
14.2.6 Merck Animal Health
14.2.7 Phibro Animal Health Corporation
14.2.8 ImmunoVet Ltd.
14.2.9 Biogenesis Bago
14.2.10 Vetoquinol S.A.
14.2.11 Hester Biosciences Limited
14.2.12 Growell India
14.2.13 Dechra Pharmaceuticals
14.2.14 Indian Immunologicals Limited
14.2.15 Aimil Animal Healthcare
-
15. Data Collection Method and Research Approach
-
16. Principal Presumptions and Acronyms
